semaglutide and cancer risk Frontiers Can GLP-1 Drugs Reduce Cancer

In the future, with the in-depth exploration of the mechanism of GLP-1R action and the development of multi-target agonists (e.g., GLP-1R/GIPR dual agonists), GLP-1R-related therapeutics are expected to make breakthroughs in a wider range of disease areas (e.g., nonalcoholic steatohepatitis, AD, etc.), providing a more precise and highly effective strategy for the treatment of metabolic diseases and related complications

The clinical principle is to titrate antihypertensives downward as weight loss progresses, not to discontinue abruptly

Ozempic also prevents the pancreas from releasing a hormone called glucagon

Zhang Q, Qu H, Chen Y, Luo X, Chen C, Xiao B, et al

Z.WarringtonJ.et al

Inositol May Improve Ovulation and Menstrual Cycles Many people with PCOS also experience irregular menstrual cycles and anovulation (a cycle without ovulation), but inositol may help